Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 1
2(66.7%)
Early Phase 1
1(33.3%)
3Total
Phase 1(2)
Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT03850197Completed

Tubomanometry and EarPopper Devices for Eustachian Tube Function Testing

Role: lead

NCT01925729Phase 1Completed

TransMEM Gas Exchange -- Project 1, Aim 2

Role: lead

NCT01925495Early Phase 1Terminated

Gas Supply, Demand and Middle Ear Gas Balance: Specific Aim 3

Role: lead

NCT01925482Phase 1Completed

Trans-Middle-Ear Mucosal Gas Exchange Project 1, Specific Aim 1

Role: lead

NCT00694421Completed

Gas Supply, Demand and Middle Ear Gas Balance: Specific Aim 2

Role: lead

All 5 trials loaded